RxDoctor Payments Data

Sheena Chew, MD

Neurology · Boston, MANPI 1780022723

Payments from drug & device makers

$349,626in general payments, 2019–2025

Across 8 payments — averaging $43,703 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$333K
  • Mitsubishi Tanabe Pharma Development America, Inc.$17K

What the payments were for

  • Grants$262,301100%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$349,626 in reported general payments places this provider in the 90th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$6,271
Medicare patients
14
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Radicava OrsEdaravone73$1,005,378
RelyvrioSod Phenylbutyrat/Taurursodiol13$161,497
Riluzole30$1,672

Paid to pharmacies, not to this prescriber.

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →